Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

552

Participants

Timeline

Start Date

November 23, 2015

Primary Completion Date

December 9, 2017

Study Completion Date

December 9, 2017

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
BEHAVIORAL

lifestyle intervention

Evaluation of lifestyle intervention combining behavioural change councelling and utilisation of E-health platform. The intervention consists of a combination of behaviour change counselling and support through six contact-points with CHPs (community health promoter) and access to a personalised mobile application.

OTHER

standard antenatal care

Standard of care for pre-pregnancy health. Subjects will be reminded of their endpoint measurement visit towards the end of the intervention period through a phone call.

Trial Locations (1)

70400

Novo Nordisk Investigational Site, Seremban, Negeri Sembilan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT02617693 - Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes | Biotech Hunter | Biotech Hunter